Helios aims to screen health risks using tiny blood samples
Models & ResearchSuperhuman · 3d ago

Helios aims to screen health risks using tiny blood samples

Medical technology startup Helios has launched a waitlist for a service that evaluates roughly 1,000 blood proteins from a few drops of blood. The company pairs a custom collection tool with an automated health advisor designed to detect emerging conditions before symptoms manifest. It was established by research scientists Omar Abudayyeh, Jonathan Gootenberg, and Yousef Badran.

HeliosOmar AbudayyehJonathan GootenbergYousef Badran

The Blend

A healthcare startup called Helios has opened a sign-up list for a service that promises to evaluate health risks using a tiny blood sample. Founded by researchers from Harvard and MIT, the venture pairs an at-home collection tool with an artificial intelligence advisor. The firm claims its technology measures roughly a thousand proteins to estimate biological aging and forecast susceptibility to hundreds of potential diseases before physical issues show up.

For regular consumers, this approach attempts to bring advanced preventative diagnostics into everyday life. Routine physical exams typically measure only a handful of basic indicators, often identifying health problems only after symptoms have already developed. If widespread protein screening proves accurate, individuals could spot cardiovascular or metabolic warning signs years ahead of time and adjust their habits accordingly.

Significant practical and medical questions remain unanswered. The startup has not revealed what the service will cost, and broad clinical trials will be necessary to prove the predictive algorithms provide meaningful clinical value rather than unnecessary anxiety. It also remains uncertain whether traditional doctors will welcome patient-driven algorithmic data or dismiss it as noise that could burden the healthcare system with unneeded follow-up tests.

Written independently by AI News Smoothie from the reporting listed below. Facts belong to the original publishers. Follow the links for their full coverage.

Ingredients

Read the original